News Wire

Jessica Blume, who sits on the company’s board of directors, led the way in buying Centene shares.
Inrebic Reduces Symptoms by 50% in Some Patients
Novel Catheter-based Technology for Treating Acute Ischemic Stroke
Decision supported by data from more than 4,000 patients
Triggers the Body’s Own Natural Blood Flow Regulation
Even though it would seem to be a natural fit, a host of cultural, regulatory and insurance barriers keep the technology at bay.
Selenious Acid Injection, used in the intravenous feeding process, is replacing Selenium, but could cost 1,300% more.
But not before EmpowerHMS allegedly bilked millions from payers and left hundreds of employees in rural areas without jobs, back pay, and health insurance.
CEO Vas Narasimhan, MD, plays defense as the FDA and lawmakers scrutinize the scandal surrounding the approval of the $2.125-million-per-treatment Zolgensma.
Zip Device Faster to Apply, Minimizes Scarring
Statistically Significant Improvement in Excessive Daytime Sleepiness
Researcher Made Himself Guinea Pig to Test the Drug
Treatment Shorter, Less Complicated Than Typical Regimen
Finding Could Spur New Targeted Treatments